Xeris Biopharma Holdings Inc. buy Oppenheimer Holdings Inc.
Start price
29.10.25
/
50%
€8.51
Target price
29.10.26
€15.45
Performance (%)
-14.85%
Price
28.07.26
€7.24
Summary
This prediction is currently active. The prediction for Xeris Biopharma Holdings Inc. disappoints with a performance of -14.85%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | -5.899% | -5.899% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) was given a new $18.00 price target on by analysts at Oppenheimer Holdings, Inc.. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€6.66
12.11.25
12.11.25
€15.55
12.11.26
12.11.26
8.82%
28.07.26
28.07.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€4.45
09.05.25
09.05.25
€6.24
09.05.26
09.05.26
22.54%
10.05.26
10.05.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.04
28.03.24
28.03.24
€4.62
28.03.25
28.03.25
154.90%
29.03.25
29.03.25